IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data



IDA2PM is a integrated database for ADMET and adverse effects based on FDA approved drug data, which have been developed as a useful resource for computational analyses and modelling. IDA2PM aims to bridge the gap by providing in a single resource, integrated detailed information on approved drugs such as structures, molecular descriptors, ADMET and adverse effects properties, target and also related bioactivity.
Date made available2017
PublisherJournal of cheminformatics
Date of data production2016

Cite this